Osaka, Japan, December 2, 2025. Luxna Biotech Co., Ltd. (President CEO: Hideaki Sato; Headquarters: Suita-shi, Osaka, Japan, hereinafter “Luxna”) and..
News & Events
Press Releases
Discover the latest updates from BioSpring! Stay informed on our milestone achievements and important announcements.
For press inquiries, please use our contact form. We look forward to your message.
November 10, 2025
From Discovery to Commercial Supply: Accelerating the Development of Therapeutic Oligonucleotide Drugs
Frankfurt a.M. / Munich, November 10th, 2025. BioSpring, a world-leading CDMO for therapeutic oligonucleotide manufacturing and analysis, and..
October 9, 2025
BioSpring Enters Strategic Partnership with Luxna Biotech to Offer Manufacture of Oligonucleotides with Luxna’s advanced XNA Amidites
Frankfurt am Main, Germany. BioSpring, a leading supplier of high-quality therapeutic oligonucleotides, today announced a new collaboration with..
August 28, 2025
The World Visits BioSpring: Consular Corps Tours Frankfurt High-Tech Company
Frankfurt am Main, Germany. Around 70 career and honorary consuls from all over the world visited the Frankfurt-based high-tech company BioSpring as..
July 3, 2025
A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs
Offenbach am Main, Germany. Groundbreaking for the future: Together with Hesse’s Minister President Boris Rhein (CDU) and the Mayor of Offenbach, Dr...
May 15, 2025
BioSpring to Participate in TIDES USA 2025 with Workshop and Scientific Presentations
San Diego, CA, USA. With over 1,900 industry experts expected to attend, TIDES USA in San Diego, USA, offers a premier platform for scientific..
January 29, 2025
Hessian State Government Holds Cabinet Meeting at BioSpring
Frankfurt am Main, Germany.The Hessian state government convened today for an external cabinet meeting at BioSpring in Frankfurt am Main. The main..
November 5, 2024
Manufacturer's authorization for cGMP mRNA
Frankfurt am Main, Germany.BioSpring, a global leader in manufacturing and analyzing nucleic acids for therapeutics and diagnostics, is now also..
September 24, 2024
Biotech - Excellence from Hesse: BioSpring's CEO Dr. Sylvia Wojczewski for talks in Brussels
Brussels, Belgium/Frankfurt am Main, Germany. " Biotechnology as a driver of innovation - success factors for a strong location" was the leitmotif of..
August 21, 2024
Hesse's Economics Minister Kaweh Mansoori visits BioSpring
Frankfurt am Main, Germany. Hesse's Economics Minister Kaweh Mansoori (SPD) and the Mayor of Offenbach, Dr. Felix Schwenke (SPD), visited BioSpring..
July 31, 2024
BioSpring and Pantherna agree on strategic cooperation in the field of genome editing
Frankfurt am Main/Hennigsdorf, Germany.BioSpring GmbH and Pantherna Therapeutics GmbH, two leading providers of therapeutic mRNA, have agreed on a..
February 9, 2024
BioSpring Event: Genome Editing – Medicine of the Future
Frankfurt am Main, Germany. BioSpring GmbH, the world's leading manufacturer of genome editing active ingredients, hosted a specialist event on the 9..
June 29, 2023
SPD State Chair Nancy Faeser and Dr. Edgar Franke visit BioSpring
Frankfurt am Main, Germany.Nancy Faeser, Federal Minister of the Interior and Home Affairs and top candidate of the SPD for the Hesse state..
March 3, 2023
State Secretary at HMWEVW Dr. Philipp Nimmermann visits BioSpring
Frankfurt am Main, Germany. Dr. Philipp Nimmermann, State Secretary in the Hessian Ministry of Economic Affairs, Energy, Transport and Housing..
February 23, 2023
Expansion on the Innovation Campus: Offenbach's Mayor Schwenke at BioSpring
Frankfurt am Main, Germany. Offenbach's Mayor Dr. Felix Schwenke visited BioSpring's production site in Frankfurt-Fechenheim on Tuesday. In December..
No results found
Learn more about our company
Explore More
Discover more about our news & upcoming events:
Upcoming Events, NewsletterDiscover more about BioSpring:
Who We Are, History, Leadership, Facilities, Quality, Sustainability